{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:44:35Z","timestamp":1772873075153,"version":"3.50.1"},"reference-count":55,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3892\/or.2014.3376","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T05:05:44Z","timestamp":1406869544000},"page":"1661-1669","source":"Crossref","is-referenced-by-count":18,"title":["Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma"],"prefix":"10.3892","volume":"32","author":[{"given":"NING","family":"JIANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FAN","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIMING","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUIXUE","family":"CUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEI","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QINGMEI","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENFEI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YING","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JING","family":"ZENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINGPING","family":"YUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XINCHUN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BOPING","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YING","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUIYUN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHUO G.","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"key20180107205737_b1-or-32-04-1661","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107205737_b2-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience","volume":"61","author":"Lee","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107205737_b3-or-32-04-1661","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety","volume":"23","author":"Wee","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107205737_b4-or-32-04-1661","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anorl.2010.10.003","article-title":"Treatment for metastatic nasopharyngeal carcinoma","volume":"128","author":"Bensouda","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"key20180107205737_b5-or-32-04-1661","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/CAD.0b013e328337160e","article-title":"Treatment approaches to nasopharyngeal carcinoma: a review","volume":"21","author":"Caponigro","year":"2010","journal-title":"Anticancer Drugs"},{"key":"key20180107205737_b6-or-32-04-1661","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1586\/14737140.6.3.383","article-title":"Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma","volume":"6","author":"Ma","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107205737_b7-or-32-04-1661","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"key20180107205737_b8-or-32-04-1661","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107205737_b9-or-32-04-1661","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107205737_b10-or-32-04-1661","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"key20180107205737_b11-or-32-04-1661","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm.2646","article-title":"The road to resistance: EGFR mutation and cetuximab","volume":"18","author":"Bardelli","year":"2012","journal-title":"Nat Med"},{"key":"key20180107205737_b12-or-32-04-1661","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1044579X02000834","article-title":"Nasopharyngeal carcinoma (NPC) is an enigmatic tumor","volume":"12","author":"Klein","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"key20180107205737_b13-or-32-04-1661","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S","article-title":"Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation","volume":"82","author":"Hui","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107205737_b14-or-32-04-1661","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0046-8177(00)80216-6","article-title":"Frequent c-myc and Int-2 over-representations in nasopharyngeal carcinoma","volume":"31","author":"Fan","year":"2000","journal-title":"Hum Pathol"},{"key":"key20180107205737_b15-or-32-04-1661","first-page":"467","article-title":"Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization","volume":"20","author":"Hui","year":"2002","journal-title":"Int J Oncol"},{"key":"key20180107205737_b16-or-32-04-1661","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg1011s57","article-title":"The Catalogue of Somatic Mutations in Cancer (COSMIC)","volume":"Chapter 10","author":"Forbes","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"key":"key20180107205737_b17-or-32-04-1661","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12032-008-9124-5","article-title":"PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival","volume":"26","author":"Chou","year":"2009","journal-title":"Med Oncol"},{"key":"key20180107205737_b18-or-32-04-1661","first-page":"319","article-title":"Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma","volume":"19","author":"Yip","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107205737_b19-or-32-04-1661","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1349-7006.2009.01292.x","article-title":"PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma","volume":"100","author":"Fendri","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107205737_b20-or-32-04-1661","first-page":"OL1442","article-title":"Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma","volume":"56","author":"Naji","year":"2010","journal-title":"Cell Mol Biol"},{"key":"key20180107205737_b21-or-32-04-1661","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5732\/cjc.009.10411","article-title":"C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines","volume":"29","author":"Huang","year":"2010","journal-title":"Chin J Cancer"},{"key":"key20180107205737_b22-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"key20180107205737_b23-or-32-04-1661","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2407-10-101","article-title":"A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes","volume":"10","author":"Fumagalli","year":"2010","journal-title":"BMC Cancer"},{"key":"key20180107205737_b24-or-32-04-1661","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107205737_b25-or-32-04-1661","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2012.10.032","article-title":"MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma","volume":"329","author":"Liu","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107205737_b26-or-32-04-1661","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.2974","article-title":"Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers","volume":"226","author":"Wetterskog","year":"2012","journal-title":"J Pathol"},{"key":"key20180107205737_b27-or-32-04-1661","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"key":"key20180107205737_b28-or-32-04-1661","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng1975","article-title":"High-throughput oncogene mutation profiling in human cancer","volume":"39","author":"Thomas","year":"2007","journal-title":"Nat Genet"},{"key":"key20180107205737_b29-or-32-04-1661","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1038\/nmeth.f.254","article-title":"Mutation profiling in tumor samples using the Sequenom OncoCarta\u2122 Panel","volume":"6","author":"Pearce","year":"2009","journal-title":"Nature Methods"},{"key":"key20180107205737_b30-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-07-5659","article-title":"PIK3CA mutation\/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab","volume":"68","author":"Jhawer","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107205737_b31-or-32-04-1661","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(10)70112-1","article-title":"Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study","volume":"11","author":"Cappuzzo","year":"2010","journal-title":"Lancet Oncology"},{"key":"key20180107205737_b32-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/1078-0432.CCR-10-1720","article-title":"KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer","volume":"17","author":"Tie","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107205737_b33-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ijc.21444","article-title":"PIK3CA mutations in nasopharyngeal carcinoma","volume":"118","author":"Or","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107205737_b34-or-32-04-1661","first-page":"589","article-title":"Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma","volume":"62","author":"Qian","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107205737_b35-or-32-04-1661","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key20180107205737_b36-or-32-04-1661","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2011.38.3224","article-title":"Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer","volume":"30","author":"Su","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107205737_b37-or-32-04-1661","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat Genet"},{"key":"key20180107205737_b38-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"key20180107205737_b39-or-32-04-1661","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107205737_b40-or-32-04-1661","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature00990","article-title":"Mantle compensation of active metamorphic core complexes at Woodlark rift in Papua New Guinea","volume":"418","author":"Abers","year":"2002","journal-title":"Nature"},{"key":"key20180107205737_b41-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1988.tb02907.x","article-title":"Primary structure of c-kit: relationship with the CSF-1\/PDGF receptor kinase family - oncogenic activation of v-kit involves deletion of extracellular domain and C terminus","volume":"7","author":"Qiu","year":"1988","journal-title":"EMBO J"},{"key":"key20180107205737_b42-or-32-04-1661","doi-asserted-by":"crossref","first-page":"e24064","DOI":"10.1371\/journal.pone.0024064","article-title":"C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation","volume":"6","author":"Phung","year":"2011","journal-title":"PLoS One"},{"key":"key20180107205737_b43-or-32-04-1661","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"key":"key20180107205737_b44-or-32-04-1661","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/labinvest.3700524","article-title":"Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation","volume":"87","author":"Nakagomi","year":"2007","journal-title":"Lab Invest"},{"key":"key20180107205737_b45-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107205737_b46-or-32-04-1661","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2004-12-4617","article-title":"Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"key":"key20180107205737_b47-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol Rev"},{"key":"key20180107205737_b48-or-32-04-1661","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10637-009-9316-7","article-title":"Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response","volume":"28","author":"Ma","year":"2010","journal-title":"Invest New Drugs"},{"key":"key20180107205737_b49-or-32-04-1661","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S1470-2045(11)70129-2","article-title":"EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications","volume":"13","author":"Yasuda","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20180107205737_b50-or-32-04-1661","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/MCB.22.2.644-656.2002","article-title":"Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence","volume":"22","author":"Rane","year":"2002","journal-title":"Mol Cell Biol"},{"key":"key20180107205737_b51-or-32-04-1661","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/joe.0.1780301","article-title":"Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours","volume":"178","author":"Vax","year":"2003","journal-title":"J Endocrinol"},{"key":"key20180107205737_b52-or-32-04-1661","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma","volume":"62","author":"Brose","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107205737_b53-or-32-04-1661","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key20180107205737_b54-or-32-04-1661","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107205737_b55-or-32-04-1661","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3376\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T08:52:48Z","timestamp":1565686368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.3892\/or.2014.3376"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3376","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}